CLOV insider filings

CLOVER HEALTH INVESTMENTS, CORP. /DE — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-17. Screen CLOV transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 23 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Toy Andrew — Chief Executive Officer, Director2—2 legs · 380,982 sh · $1,626,781—
Wai Conrad — CEO, Counterpart Health2—2 legs · 323,627 sh · $1,526,574—
Reynoso Jamie L. — CEO, Medicare Advantage6—6 legs · 44,289 sh · $204,496—
Soares Karen — Chief Legal Officer3—3 legs · 40,794 sh · $191,215—
THORNTON JOSEPH CLAY — Chief Financial Officer3—2 legs · 26,690 sh · $131,3181
OLDAKOWSKI JOSEPH FRANK — Chief Accounting Officer3—2 legs · 23,170 sh · $117,9091
Miller Brian James — Director2——1
Torricelli Robert G — Director2——1

Recent insider filings — CLOVER HEALTH INVESTMENTS, CORP. /DE

FiledFormInsiderReported transactionsSource
2026-11-174THORNTON JOSEPH CLAY — Chief Financial OfficerSale (S): 22,099 @ $4.97EDGAR
2026-11-064OLDAKOWSKI JOSEPH FRANK — Chief Accounting OfficerGrant/award (A): 186,403 @ $0EDGAR
2026-11-064THORNTON JOSEPH CLAY — Chief Financial OfficerGrant/award (A): 328,947 @ $0EDGAR
2026-10-204Soares Karen — Chief Legal OfficerSale (S): 19,275 @ $4.66EDGAR
2026-10-204Reynoso Jamie L. — CEO, Medicare AdvantageSale (S): 4,066 @ $4.41EDGAR
2026-10-194Toy Andrew — Chief Executive Officer, DirectorSale (S): 62,176 @ $4.68EDGAR
2026-10-194Soares Karen — Chief Legal OfficerSale (S): 14,673 @ $4.68EDGAR
2026-10-194THORNTON JOSEPH CLAY — Interim CFOSale (S): 4,591 @ $4.68EDGAR
2026-10-194Wai Conrad — CEO, Counterpart HealthSale (S): 23,627 @ $4.68EDGAR
2026-10-194Reynoso Jamie L. — CEO, Medicare AdvantageSale (S): 18,273 @ $4.68EDGAR
2026-10-074Reynoso Jamie L. — CEO, Medicare AdvantageSale (S): 2,006 @ $4.63EDGAR
2026-10-054Reynoso Jamie L. — CEO, Medicare AdvantageSale (S): 8,750 @ $4.42EDGAR
2026-10-024Torricelli Robert G — DirectorGrant/award (A): 12,481 @ $0EDGAR
2026-10-024Miller Brian James — DirectorGrant/award (A): 12,481 @ $0EDGAR
2026-10-024Toy Andrew — Chief Executive Officer, DirectorSale (S): 318,806 @ $4.19EDGAR
2026-10-013Torricelli Robert G — DirectorHoldings only — no transactions reportedEDGAR
2026-10-013Miller Brian James — DirectorHoldings only — no transactions reportedEDGAR
2026-09-184Reynoso Jamie L. — CEO, Medicare AdvantageSale (S): 1,921 @ $4.56EDGAR
2026-09-174OLDAKOWSKI JOSEPH FRANK — VP OF FINANCE AND CONTROLLERSale (S): 3,170 @ $4.64EDGAR
2026-09-164Wai Conrad — CEO, Counterpart HealthSale (S): 300,000 @ $4.72EDGAR
2026-09-154Soares Karen — Chief Legal OfficerSale (S): 6,846 @ $4.78EDGAR
2026-09-154Reynoso Jamie L. — CEO, Medicare AdvantageSale (S): 9,273 @ $4.78EDGAR
2026-09-144OLDAKOWSKI JOSEPH FRANK — VP OF FINANCE AND CONTROLLERSale (S): 20,000 @ $5.16EDGAR
2026-08-174THORNTON JOSEPH CLAY — Interim CFOSale (S): 17,775 @ $4.39EDGAR
2026-08-134Soares Karen — Chief Legal OfficerGrant/award (A): 108,695 @ $0EDGAR
2026-08-134THORNTON JOSEPH CLAY — Interim CFOGrant/award (A): 54,347 @ $0EDGAR
2026-08-104Toy Andrew — Chief Executive Officer, DirectorSale (S): 87,798 @ $4.65EDGAR
2026-07-204Soares Karen — Chief Legal OfficerSale (S): 51,700 @ $4.51EDGAR
2026-07-174Reynoso Jamie L. — CEO, Medicare AdvantageSale (S): 4,839 @ $4.53EDGAR
2026-07-164Toy Andrew — Chief Executive Officer, DirectorSale (S): 62,711 @ $4.67EDGAR
2026-07-164Wai Conrad — CEO, Counterpart HealthSale (S): 24,215 @ $4.67EDGAR
2026-07-164Reynoso Jamie L. — CEO, Medicare AdvantageSale (S): 13,119 @ $4.67EDGAR
2026-07-164Soares Karen — Chief Legal OfficerSale (S): 10,519 @ $4.67EDGAR
2026-07-164THORNTON JOSEPH CLAY — Interim CFOSale (S): 4,630 @ $4.67EDGAR
2026-07-094Reynoso Jamie L. — CEO, Medicare AdvantageSale (S): 2,384 @ $4.68EDGAR
2026-07-064Reynoso Jamie L. — CEO, Medicare AdvantageSale (S): 6,229 @ $5.26EDGAR
2026-07-014Toy Andrew — Chief Executive Officer, DirectorSale (S): 313,476 @ $5.32EDGAR
2026-06-184Reynoso Jamie L. — CEO, Medicare AdvantageSale (S): 2,360 @ $4.78EDGAR
2026-06-174OLDAKOWSKI JOSEPH FRANK — VP OF FINANCE AND CONTROLLERSale (S): 12,102 @ $4.86EDGAR
2026-06-164Reynoso Jamie L. — CEO, Medicare AdvantageSale (S): 6,350 @ $4.61EDGAR
2026-06-164Soares Karen — Chief Legal OfficerSale (S): 4,681 @ $4.61EDGAR
2026-06-114Reynoso Jamie L. — CEO, Medicare AdvantageSale (S): 7,289 @ $4.91EDGAR
2026-05-284Wai Conrad — CEO, Counterpart HealthSale (S): 220,426 @ $3.99EDGAR
2026-05-194Edwards Carladenise Armbrister — DirectorSale (S): 67,160 @ $3.42EDGAR
2026-05-184THORNTON JOSEPH CLAY — Interim CFOTax withholding (F): 16,942 @ $3.47EDGAR
2026-05-134Priest Brady Patrick — CEO of Clover Care ServicesSale (S): 98,039 @ $3.52EDGAR
2026-05-124Toy Andrew — Chief Executive Officer, DirectorTax withholding (F): 85,704 @ $2.82EDGAR
2026-04-214Priest Brady Patrick — CEO of Clover Care ServicesTax withholding (F): 36,113 @ $2.19EDGAR
2026-04-164Toy Andrew — Chief Executive Officer, DirectorTax withholding (F): 60,765 @ $2.04EDGAR
2026-04-164THORNTON JOSEPH CLAY — Interim CFOTax withholding (F): 4,158 @ $2.04EDGAR

Recent 8-K events — CLOVER HEALTH INVESTMENTS, CORP. /DE

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-168-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-048-K2.02 — Results of Operations and Financial Condition
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-098-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-258-K/A5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-248-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-208-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-178-K8.01 — Other EventsEDGAR
2026-06-188-K8.01 — Other EventsEDGAR
2026-06-168-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CLOV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs